Abstract
Neurodegeneration is a prevalent and one of the emerging reasons for morbidity, mortality, and cognitive impairment in aging. Dementia is one of such conditions of neurodegeneration, partially manageable, irreversible, and worsens over time. This review is focused on biological and psychosocial risk factors associated with Alzheimer’s and Parkinson’s diseases, highlighting the value of cognitive decline. We further emphasized on current therapeutic strategies from pharmacological and non-pharmacological perspectives focusing on their effects on cognitive impairment, protein aggregation, tau pathology, and improving the quality of life. Deeper mechanistic insights into the multifactorial neurodegeneration could offer the design and development of promising diagnostic and therapeutic strategies.
| Original language | English |
|---|---|
| Pages (from-to) | 2739-2752 |
| Number of pages | 14 |
| Journal | Molecular and Cellular Biochemistry |
| Volume | 476 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Alzheimer’s disease; Parkinson’s disease
- Neurodegeneration
- Neurodegenerative diseases
- Therapeutic management
Fingerprint
Dive into the research topics of 'Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver